Japan · Delayed Price · Currency is JPY TRIAL Holdings Statistics
Total Valuation
TRIAL Holdings has a market cap or net worth of JPY 401.47 billion. The enterprise value is 736.41 billion.
| Market Cap | 401.47B |
| Enterprise Value | 736.41B |
Important Dates
The next confirmed earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
TRIAL Holdings has 122.77 million shares outstanding. The number of shares has increased by 0.76% in one year.
| Current Share Class | 122.77M |
| Shares Outstanding | 122.77M |
| Shares Change (YoY) | +0.76% |
| Shares Change (QoQ) | -0.99% |
| Owned by Insiders (%) | 2.03% |
| Owned by Institutions (%) | 0.49% |
| Float | 41.80M |
Valuation Ratios
The trailing PE ratio is 43.32 and the forward PE ratio is 42.65. TRIAL Holdings's PEG ratio is 7.78.
| PE Ratio | 43.32 |
| Forward PE | 42.65 |
| PS Ratio | 0.33 |
| PB Ratio | 2.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.95 |
| P/OCF Ratio | 4.80 |
| PEG Ratio | 7.78 |
Enterprise Valuation
| EV / Earnings | 79.18 |
| EV / Sales | 0.61 |
| EV / EBITDA | n/a |
| EV / EBIT | 23.87 |
| EV / FCF | 16.42 |
Financial Position
The company has a current ratio of 0.32, with a Debt / Equity ratio of 2.92.
| Current Ratio | 0.32 |
| Quick Ratio | 0.14 |
| Debt / Equity | 2.92 |
| Debt / EBITDA | n/a |
| Debt / FCF | 8.74 |
| Interest Coverage | 10.12 |
Financial Efficiency
Return on equity (ROE) is 7.55% and return on invested capital (ROIC) is 2.70%.
| Return on Equity (ROE) | 7.55% |
| Return on Assets (ROA) | 3.62% |
| Return on Invested Capital (ROIC) | 2.70% |
| Return on Capital Employed (ROCE) | 14.95% |
| Weighted Average Cost of Capital (WACC) | 5.61% |
| Revenue Per Employee | 170.54M |
| Profits Per Employee | 1.31M |
| Employee Count | 7,080 |
| Asset Turnover | 2.29 |
| Inventory Turnover | 13.32 |
Taxes
In the past 12 months, TRIAL Holdings has paid 15.59 billion in taxes.
| Income Tax | 15.59B |
| Effective Tax Rate | 61.39% |
Stock Price Statistics
The stock price has increased by +35.24% in the last 52 weeks. The beta is 1.19, so TRIAL Holdings's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +35.24% |
| 50-Day Moving Average | 2,939.36 |
| 200-Day Moving Average | 3,192.35 |
| Relative Strength Index (RSI) | 65.82 |
| Average Volume (20 Days) | 476,810 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TRIAL Holdings had revenue of JPY 1.21 trillion and earned 9.30 billion in profits. Earnings per share was 75.48.
| Revenue | 1.21T |
| Gross Profit | 281.57B |
| Operating Income | 30.47B |
| Pretax Income | 25.39B |
| Net Income | 9.30B |
| EBITDA | n/a |
| EBIT | 30.47B |
| Earnings Per Share (EPS) | 75.48 |
Balance Sheet
The company has 60.47 billion in cash and 392.13 billion in debt, with a net cash position of -331.65 billion or -2,701.34 per share.
| Cash & Cash Equivalents | 60.47B |
| Total Debt | 392.13B |
| Net Cash | -331.65B |
| Net Cash Per Share | -2,701.34 |
| Equity (Book Value) | 134.16B |
| Book Value Per Share | 1,067.07 |
| Working Capital | -393.11B |
Cash Flow
In the last 12 months, operating cash flow was 83.72 billion and capital expenditures -38.86 billion, giving a free cash flow of 44.86 billion.
| Operating Cash Flow | 83.72B |
| Capital Expenditures | -38.86B |
| Depreciation & Amortization | 15.27B |
| Net Borrowing | 337.47B |
| Free Cash Flow | 44.86B |
| FCF Per Share | 365.40 |
Margins
Gross margin is 23.32%, with operating and profit margins of 2.52% and 0.77%.
| Gross Margin | 23.32% |
| Operating Margin | 2.52% |
| Pretax Margin | 2.10% |
| Profit Margin | 0.77% |
| EBITDA Margin | n/a |
| EBIT Margin | 2.52% |
| FCF Margin | 4.14% |
Dividends & Yields
This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.49%.
| Dividend Per Share | 16.00 |
| Dividend Yield | 0.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.76% |
| Shareholder Yield | -0.27% |
| Earnings Yield | 2.32% |
| FCF Yield | 11.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for TRIAL Holdings is 4,462.50, which is 36.47% higher than the current price. The consensus rating is "Buy".
| Price Target | 4,462.50 |
| Price Target Difference | 36.47% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 23.95% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TRIAL Holdings has an Altman Z-Score of 1.52 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.52 |
| Piotroski F-Score | 5 |